MedTrace Logo

Cognitive and Motor Tasks in Cerebral Palsy

NCT04850690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-04-20

No results posted yet for this study

Summary

Various gait deviations are observed in children with cerebral palsy. Our aim was to determine the effect of cognitive task (CT) and motor task (MT) on gait in children with cerebral palsy (CP). 15 children with CP, between 9-15 years old, with Communication Function Classification System (CFSS) level I, with Gross Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS) level I-II were included in the study. The gait with four different conditions (single gait, CT, MT and CT\&MT) was evaluated by Kinovea video analysis method on a 10-meter course.

Results:

Conditions

  • Cerebral Palsy
  • Gait Disorders, Neurologic
  • Cognitive Orientation
  • Motor Activity

Interventions

DIAGNOSTIC_TEST

2D Gait analysis

The gait with four different conditions (single gait, Cognitive Task, Motor Task and Cognitive Task\&Motor Task) was evaluated by Kinovea video analysis method on a 10-meter course. * Single: Walking without task at a self-selected speed * Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes * Motor Task (MT): Walking while carrying an empty box * CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes

Sponsors & Collaborators

  • Istanbul Medipol University Hospital

    lead OTHER

Principal Investigators

  • Miray BUDAK, PhD · Medipol University

Eligibility

Min Age
9 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-05-01
Completion
2019-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04850690 on ClinicalTrials.gov